Fig. 4From: Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicitySG003 had no/weak cross-reactivity to a series of glycoproteins. a flow cytometry analysis of SG003 to bind 293 T cells (CD38 negative); b SG003 didn’t bind to the extracellular domain of many receptors, e.g. CD47, CD19, BSA, etc. by ELISA detectionBack to article page